TY - JOUR
T1 - Ototoxic effect of daptomycin applied to the guinea pig middle ear
AU - Oshima, Hidetoshi
AU - Nomura, Kazuhiro
AU - Yamazaki, Muneharu
AU - Suzuki, Jun
AU - Kawase, Tetsuaki
AU - Kobayashi, Toshimitsu
AU - Katori, Yukio
N1 - Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 2014/7
Y1 - 2014/7
N2 - Conclusion: Daptomycin applied topically at a concentration of 50 mg/ml caused mild but statistically significant hearing impairment. Outer hair cells were not damaged by daptomycin. Great care must be taken when there is a chance that daptomycin can reach the middle ear. Objective: Ototopic antibiotic eardrops are frequently used to treat external and middle ear infections. Daptomycin is a new anti-methicillin-resistant Staphylococccus aureus (MRSA) drug with unknown ototoxicity. The current study examined the ototoxic effect of daptomycin in topical applications to guinea pig ears. Methods: Twenty-three male Hartley guinea pigs (weight, 250-640 g) were divided into three groups receiving daptomycin (50 mg/ml), gentamicin (50 mg/ml, positive control), or saline solution (negative control). After insertion of a pressure-equalizing tube, pretreatment auditory brainstem responses (ABRs) were obtained. Topical solutions of 0.1 ml were applied through the tube into the middle ear twice a day for 7 days. Post-treatment ABRs were obtained 7 days after the last treatment. Hair cell loss was investigated with whole-mount cochlear surface preparations. Results: The saline-treated (negative control) group showed no deterioration of ABR threshold. The daptomycin-treated group showed mild deterioration and the gentamicin-treated group showed severe deterioration in ABR threshold. Hair cells were preserved in the daptomycin- and saline-treated groups but severely damaged in the gentamicin group.
AB - Conclusion: Daptomycin applied topically at a concentration of 50 mg/ml caused mild but statistically significant hearing impairment. Outer hair cells were not damaged by daptomycin. Great care must be taken when there is a chance that daptomycin can reach the middle ear. Objective: Ototopic antibiotic eardrops are frequently used to treat external and middle ear infections. Daptomycin is a new anti-methicillin-resistant Staphylococccus aureus (MRSA) drug with unknown ototoxicity. The current study examined the ototoxic effect of daptomycin in topical applications to guinea pig ears. Methods: Twenty-three male Hartley guinea pigs (weight, 250-640 g) were divided into three groups receiving daptomycin (50 mg/ml), gentamicin (50 mg/ml, positive control), or saline solution (negative control). After insertion of a pressure-equalizing tube, pretreatment auditory brainstem responses (ABRs) were obtained. Topical solutions of 0.1 ml were applied through the tube into the middle ear twice a day for 7 days. Post-treatment ABRs were obtained 7 days after the last treatment. Hair cell loss was investigated with whole-mount cochlear surface preparations. Results: The saline-treated (negative control) group showed no deterioration of ABR threshold. The daptomycin-treated group showed mild deterioration and the gentamicin-treated group showed severe deterioration in ABR threshold. Hair cells were preserved in the daptomycin- and saline-treated groups but severely damaged in the gentamicin group.
KW - Drug-resistant
KW - Eardrop
KW - Hearing
KW - Methicillin-resistant Staphylococcus aureus
KW - Topical
KW - Vancomycin
UR - http://www.scopus.com/inward/record.url?scp=84902579619&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902579619&partnerID=8YFLogxK
U2 - 10.3109/00016489.2014.898186
DO - 10.3109/00016489.2014.898186
M3 - Article
C2 - 24834938
AN - SCOPUS:84902579619
SN - 0001-6489
VL - 134
SP - 679
EP - 683
JO - Acta Oto-Laryngologica
JF - Acta Oto-Laryngologica
IS - 7
ER -